Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Form 8-K

sec.gov

8-K — Option Care Health, Inc.

Accession: 0001104659-26-058979

Filed: 2026-05-12

Period: 2026-05-12

CIK: 0001014739

SIC: 8082 (SERVICES-HOME HEALTH CARE SERVICES)

Item: Regulation FD Disclosure

Item: Financial Statements and Exhibits

Documents

8-K — tm2614211d1_8k.htm (Primary)

EX-99.1 — EXHIBIT 99.1 (tm2614211d1_ex99-1.htm)

GRAPHIC (tm2614211d1_8kimg001.jpg)

GRAPHIC (tm2614211d1_ex99-1img001.jpg)

GRAPHIC (tm2614211d1_ex99-1img002.jpg)

GRAPHIC (tm2614211d1_ex99-1img003.jpg)

GRAPHIC (tm2614211d1_ex99-1img004.jpg)

GRAPHIC (tm2614211d1_ex99-1img005.jpg)

GRAPHIC (tm2614211d1_ex99-1img006.jpg)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K — FORM 8-K

8-K (Primary)

Filename: tm2614211d1_8k.htm · Sequence: 1

false

0001014739

0001014739

2026-05-12

2026-05-12

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington,

D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date

of Report (Date of earliest event reported)

May 12, 2026

OPTION

CARE HEALTH, INC.

(Exact name of registrant as specified in its charter)

Delaware

001-11993

05-0489664

(State or other jurisdiction of

incorporation)

(Commission File Number)

(IRS

Employer Identification Number)

3000 Lakeside Dr. Suite 300N, Bannockburn, IL 60015

(Address

of principal executive offices)

(312) 940-2443

(Registrant's

telephone number, including area code)

Check the appropriate box below if the

Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following

provisions:

¨ Written communications pursuant to Rule 425 under

the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under

the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under

the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under

the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant

is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2

of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging

growth company ¨

If

an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period

for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the

Exchange Act. ¨

Securities registered pursuant to Section 12(b) of

the Act:

Title of each Class

Trading Symbol(s)

Name of each exchange on which registered

Common

Stock, $0.0001 par value per share

OPCH

Nasdaq Global Select Market

Item 7.01 Regulation FD Disclosure.

On

May 12, 2026, Option Care Health, Inc. (the “Company”) management will participate in

the Bank of America Health Care Conference. An investor presentation that the Company intends to use in connection with this conference

and other meetings is attached hereto as Exhibit 99.1 and will also be posted on the Company’s Investor Relations website.

The information under 7.01 of this Report and the exhibits

referenced therein shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended

(the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated

by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific

reference in such filing.

Item 9.01. Financial Statements and Exhibits

(d) Exhibits.

Exhibit

Number

Exhibit Description

99.1

Presentation dated May 12, 2026

104

Cover Page Interactive Data File (embedded within the inline XBRL document)

SIGNATURES

Pursuant to the requirements

of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto

duly authorized.

Option Care Health, Inc.

Date: May 12, 2026

By:

/s/ Meenal Sethna

Meenal Sethna

Chief Financial Officer

EX-99.1 — EXHIBIT 99.1

EX-99.1

Filename: tm2614211d1_ex99-1.htm · Sequence: 2

Exhibit 99.1

Extraordinary Care That Changes Lives © 2026 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED Option Care Health, Inc. Bank of America Global Healthcare Conference May 12, 2026 1

© 2026 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED Disclaimers Forward - Looking Statements This presentation may contain “forward - looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward - looking statements can be identified by words such as: “anticipate,” “intend,” “plan,” “believe,” “project,” “estimate,” “expect,” “may,” “shoul d,” “will” and similar references to future periods. Examples of forward - looking statements include, among others, statements we may make regarding future revenues, future earnings, other future financial r esu lts, regulatory developments, market developments, new products and growth strategies, and the effects of any of the foregoing on our future results of operations or financial conditions. Forward - looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on ou r current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future condition s. Because forward - looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward - looking statements. Importa nt factors that could cause our actual results and financial condition to differ materially from those indicated in the forward - looking statements include, among others, the following: changes in laws, regulations or trade policies applicable to our business model; loss of relationships with managed care organizations and other non - governmental third party payers; changes in the pharmaceutical indus try, including limiting or discontinuing research, development, production and marketing of pharmaceuticals compatible with our services; changes in market conditions and receptivity to our se rvices and offerings; and pending and future litigation or potential liability for claims not covered by insurance. For a detailed discussion of the risk factors that could affect our actual res ult s, please refer to the risk factors identified in our reports as filed with the SEC. Any forward - looking statement made by us in this presentation is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward - looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise. Non - GAAP Measures During the presentation, in addition to reporting financial information in accordance with generally accepted accounting prin cip les (“GAAP”), we may refer to non - GAAP financial measures. Management believes that these adjusted measures provide useful supplemental information regarding the performance of our bus ine ss operations and facilitate comparisons to our historical operating results. However, these non - GAAP measures are not measurements of financial performance under GAAP and should not be u sed in isolation or as a substitute or alternative to performance measures derived in accordance with GAAP. In addition, our definitions of certain non - GAAP measures may not be comparable to sim ilarly titled non - GAAP financial measures reported by other companies. Additional information on any of these non - GAAP measures can be found on the Investor Relations portion of our websit e. 2 Bank of America Investor Presentation | May 2026

© 2026 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED Option Care Health is a Leading Independent Provider of Home and Alternate Site Infusion Services National Scale with Local Responsiveness o Resilient full - service network that supports a broad set of clinical services across a variety of care sites o Proven track record of disciplined capital allocation o Consistent strong cash flow generation and attractive capital structure 315,000+ Patients Served in 2025 5,000+ Multidisciplinary Clinicians 190+ Locations in the U.S 750+ Infusion Chairs 3 ~90 Full - Service Pharmacies Licensed in all 50 states Top 10 Payers In - Network 96% Coverage to Insured Lives 1 Care Management Center (CMC) is defined as a location with both a pharmacy and AIS. Total count includes a small number of st and - alone pharmacies. 2 AIS = Ambulatory Infusion Suite | AIC = Ambulatory Infusion Clinic (Advanced Practitioner Model) Stand - alone AIS and/or AIC 2 Care Management Center 1 Bank of America Investor Presentation | May 2026

© 2026 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED 4 Secular and Industry Trends Driving Toward Lower - Cost Home and Alternate Site Care Shifting Patient Demographics • Aging population and rising disease complexity increase care needs • Growing patient preference for ‘aging - in - place’ Site - of - Care Preference • Higher - acuity patients increasingly managed outside inpatient & hospital outpatient settings • Payor pressure drives focus on lower - cost care settings Pharmaceutical Innovation • Expansion of specialty, biologic, and Rare & Orphan drugs • New launches, biosimilars & self - admin therapies Technology & Data Evolution • Greater use of analytics & digital care tools • Automation, improved efficiency, coordination and outcomes visibility Policy & Reimbursement Landscape • Ongoing reimbursement and cost containment • Increased focus on value, outcomes, and total cost of care Bank of America Investor Presentation | May 2026

© 2026 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED 5 2026 Priorities o Taking decisive actions to reaccelerate revenue growth trajectory and drive greater long - term value creation o Near - term capital allocation reprioritization , focusing on i nternal investments for profitable growth and share repurchases o Focused on rebuilding momentum from reset through coverage, conversion, and enhanced service levels Bank of America Investor Presentation | May 2026 Drive Sustainable Growth and Long - Term Value Creation

Contact Us Our Website © 2026 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED investors@optioncarehealth.com optioncarehealth.com 6 Bank of America Investor Presentation | May 2026

GRAPHIC

GRAPHIC

Filename: tm2614211d1_8kimg001.jpg · Sequence: 6

Binary file (10586 bytes)

Download tm2614211d1_8kimg001.jpg

GRAPHIC

GRAPHIC

Filename: tm2614211d1_ex99-1img001.jpg · Sequence: 7

Binary file (167431 bytes)

Download tm2614211d1_ex99-1img001.jpg

GRAPHIC

GRAPHIC

Filename: tm2614211d1_ex99-1img002.jpg · Sequence: 8

Binary file (240812 bytes)

Download tm2614211d1_ex99-1img002.jpg

GRAPHIC

GRAPHIC

Filename: tm2614211d1_ex99-1img003.jpg · Sequence: 9

Binary file (203099 bytes)

Download tm2614211d1_ex99-1img003.jpg

GRAPHIC

GRAPHIC

Filename: tm2614211d1_ex99-1img004.jpg · Sequence: 10

Binary file (190620 bytes)

Download tm2614211d1_ex99-1img004.jpg

GRAPHIC

GRAPHIC

Filename: tm2614211d1_ex99-1img005.jpg · Sequence: 11

Binary file (130212 bytes)

Download tm2614211d1_ex99-1img005.jpg

GRAPHIC

GRAPHIC

Filename: tm2614211d1_ex99-1img006.jpg · Sequence: 12

Binary file (103372 bytes)

Download tm2614211d1_ex99-1img006.jpg

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 14

v3.26.1

Cover

May 12, 2026

Cover [Abstract]

Document Type

8-K

Amendment Flag

false

Document Period End Date

May 12, 2026

Entity File Number

001-11993

Entity Registrant Name

OPTION

CARE HEALTH, INC.

Entity Central Index Key

0001014739

Entity Tax Identification Number

05-0489664

Entity Incorporation, State or Country Code

DE

Entity Address, Address Line One

3000 Lakeside Dr. Suite 300N

Entity Address, City or Town

Bannockburn

Entity Address, State or Province

IL

Entity Address, Postal Zip Code

60015

City Area Code

312

Local Phone Number

940-2443

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Title of 12(b) Security

Common

Stock, $0.0001 par value per share

Trading Symbol

OPCH

Security Exchange Name

NASDAQ

Entity Emerging Growth Company

false

X

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

na

Period Type:

duration

X

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

na

Period Type:

duration

X

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

na

Period Type:

duration

X

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration